The preclinical efficacy of the novel hypomethylating agent NTX-301 as a monotherapy and in combination with venetoclax in acute myeloid leukemia.
Ontology highlight
SUBMITTER: Lim B
PROVIDER: S-EPMC9001641 | biostudies-literature | 2022 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA